Hutch News

Richard Klausner, ex-NCI head, joins center as senior adviser

Oct. 17, 2002

Dr. Richard Klausner, director of the National Cancer Institute from 1995 to 2001, has joined Fred Hutchinson as an affiliate member and senior adviser. Informally and at leadership meetings, he will advise the center on directions for medical research.

Dr. Lee Hartwell, center president and director, said Klausner, a global leader in the application of biomedical research to public health, brings valuable insight at a time when cancer research is moving in exciting directions.

"We are delighted to have Rick associated with the center and look forward to his counsel," he said. "He is one of the most energetic, well-informed and imaginative people I have ever known."

While he will have no specific division affiliation, Klausner will maintain an office at D5-114 on the fifth floor of the Thomas Building.

Klausner also is executive director of the global-health program of the Bill & Melinda Gates Foundation. He leads the organization's effort to reduce the disease burden in the developing world through initiatives infectious diseases; HIV/AIDS and tuberculosis; and reproductive and child health.

In a seminar later this year, faculty and staff will hear Klausner's vision for the foundation.

His research focuses on applying molecular and cell biology to cancer and other diseases, most recently von Hippel-Lindau disease, a genetic abnormality that predisposes individuals to renal and other tumors.

He is a member of the National Academy of Sciences and the Institute of Medicine and has served as senior fellow and special adviser to the presidents of the National Academies for Counter Terrorism and Liaison to the White House.

No tags to display. Taglist will not be shown.


For the Media

News releases >
Media coverage >
Contact us >


Story Archive


Publications

Quest
Our quarterly magazine

Annual Report
Fiscal year highlights

Science Spotlight
Monthly review of Center-authored papers


Fred Hutch News

Get updates via email.